Source: Eur Respir J 2003; 21: 779-784
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Marrie T.J., Peeling R.W., Reid T., De Carolis E., the Canadian Comm.... Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003; 21: 779-784

Member's Comments

No comment yet.

Related content which might interest you: Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Severe Chlamydia pneumoniae community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003 Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections Source: Eur Respir J 2009; 33: 360-367 Year: 2009 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 The role of Chlamydia species as a cause of community-acquired pneumonia - clinical characteristics Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Clinical aspects of chlamydia pneumoniae pneumonia in adults Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings Source: Eur Respir J 2004; 24: Suppl. 48, 488s Year: 2004 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Atypical pathogens and respiratory tract infections Source: Eur Respir J 2004; 24: 171-182 Year: 2004 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Chlamydia pneumoniae infection in asthmatic patients Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009